Fascia Iliaca Block Versus Intravenous Dexmedetomidine and Ketamine for Positioning Fracture Femur
NCT ID: NCT05705726
Last Updated: 2023-10-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
70 participants
INTERVENTIONAL
2023-02-11
2024-07-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
the study aim to compare the analgesic effect of intravenous dexmedetomidine and fascia iliaca block preoperatively to assist positioning patients for performance of spinal anesthesia.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Fascia Iliaca Compartment Block for Proximal-end Femur Fractures
NCT02696915
Dexmedetomidine and Bupivacaine With Bupivacaine in Ultrasonography Guided Fascia Iliaca Compartment Block in Adults
NCT02658760
Dexmedetomidine Addition to Fascia Iliaca Compartment Block
NCT01600027
Fascia Iliaca Compartment Block Versus Anterior Quadratus Lumborum Block
NCT04709211
Blind Fascia Iliaca Compartment Block Compared to Ultrasound-guided Femoral Nerve Block in Patients With Hip Fractures
NCT05365555
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
facia iliaca block
ultrasound guided facia iliaca block
Patient will received ultrasound guided fascia iliaca block by 20 ml Bupivacaine 0,25% .
Precedex and ketamine
Intravenous drug
Patient will received intravenous injection of precedex 0.25mic/Kg and ketamine 0,2 mg/kg .
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ultrasound guided facia iliaca block
Patient will received ultrasound guided fascia iliaca block by 20 ml Bupivacaine 0,25% .
Intravenous drug
Patient will received intravenous injection of precedex 0.25mic/Kg and ketamine 0,2 mg/kg .
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Hip fractures
3. Both sexes.
Exclusion Criteria
2. Allergy to local anesthetics
3. Bleeding diathesis or history of anticoagulant use.
4. impaired cognition or dementia
5. . Infection of the skin at the site of needle punctures area
6. multiple fractures
7. Any previous analgesic administration during the last 12 hours
18 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Minia University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hassan Mokhtar Elshorbagy Hetta
lecturer of anesthesia and ICU
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
hassan m. hetta, lecturer
Role: PRINCIPAL_INVESTIGATOR
Minia University, faculty of medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Minia University Hospital
Minya, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
524/2022
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.